Literature DB >> 17875368

Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.

Dennis McCarty1, Bret Fuller, Lee Ann Kaskutas, William W Wendt, Edward V Nunes, Michael Miller, Robert Forman, Kathryn M Magruder, Cynthia Arfken, Marc Copersino, Anthony Floyd, Jody Sindelar, Eldon Edmundson.   

Abstract

Drug abuse treatment programs and university-based research centers collaborate to test emerging therapies for alcohol and drug disorders in the National Drug Abuse Treatment Clinical Trials Network (CTN). Programs participating in the CTN completed Organizational Surveys (n=106 of 112; 95% response rate) and Treatment Unit Surveys (n=348 of 384; 91% response rate) to describe the levels of care, ancillary services, patient demographics, patient drug use and co-occurring conditions. Analyses describe the corporations participating in the CTN and provide an exploratory assessment of variation in treatment philosophies. A diversity of treatment centers participate in the CTN; not for profit organizations with a primary mission of treating alcohol and drug disorders dominate. Compared to National Survey of Substance Abuse Treatment Services (N-SSATS), programs located in medical settings are over-represented and centers that are mental health clinics are under-represented. Outpatient, methadone, long-term residential and inpatient treatment units differed on patients served and services provided. Larger programs with higher counselor caseloads in residential settings reported more social model characteristics. Programs with higher social model scores were more likely to offer self-help meetings, vocational services and specialized services for women. Conversely, programs with accreditation had less social model influence. The CTN is an ambitious effort to engage community-based treatment organizations into research and more fully integrate research and practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875368      PMCID: PMC2223274          DOI: 10.1016/j.drugalcdep.2007.08.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

2.  Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.

Authors:  Lori J Ducharme; Hannah K Knudsen; Paul M Roman; J Aaron Johnson
Journal:  J Subst Abuse Treat       Date:  2007-02-22

Review 3.  Improving drug addiction treatment in China.

Authors:  Yi-Lang Tang; Wei Hao
Journal:  Addiction       Date:  2007-07       Impact factor: 6.526

Review 4.  Measuring treatment philosophy: a scale for substance abuse recovery programs.

Authors:  L A Kaskutas; T K Greenfield; T J Borkman; J A Room
Journal:  J Subst Abuse Treat       Date:  1998 Jan-Feb

5.  Controlled drinking as a treatment goal in Australian alcohol treatment agencies.

Authors:  S Dawe; R Richmond
Journal:  J Subst Abuse Treat       Date:  1997 Jan-Feb

6.  Buprenorphine diffusion: the attitudes of substance abuse treatment counselors.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman; Tanja Link
Journal:  J Subst Abuse Treat       Date:  2005-09

7.  Research to practice: adoption of naltrexone in alcoholism treatment.

Authors:  Cindy Parks Thomas; Stanley S Wallack; Sue Lee; Dennis McCarty; Robert Swift
Journal:  J Subst Abuse Treat       Date:  2003-01

8.  Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs.

Authors:  Dennis McCarty; Bret E Fuller; Cynthia Arfken; Michael Miller; Edward V Nunes; Eldon Edmundson; Marc Copersino; Anthony Floyd; Robert Forman; Reesa Laws; Kathy M Magruder; Mark Oyama; Kristi Prather; Jody Sindelar; William W Wendt
Journal:  Psychiatr Serv       Date:  2007-02       Impact factor: 3.084

  8 in total
  33 in total

1.  Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)): Severity of use and positive appeal of use.

Authors:  Paul A Pilkonis; Lan Yu; Nathan E Dodds; Kelly L Johnston; Suzanne M Lawrence; Thomas F Hilton; Dennis C Daley; Ashwin A Patkar; Dennis McCarty
Journal:  Drug Alcohol Depend       Date:  2015-09-21       Impact factor: 4.492

2.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

3.  Implementation of Network for the Improvement of Addiction Treatment (NIATx) Processes in Substance Use Disorder Treatment Centers.

Authors:  Dail Fields; Hannah K Knudsen; Paul M Roman
Journal:  J Behav Health Serv Res       Date:  2016-07       Impact factor: 1.505

4.  The substance abuse counseling workforce: education, preparation, and certification.

Authors:  Traci Rieckmann; Christiane Farentinos; Carrie J Tillotson; Jonathan Kocarnik; Dennis McCarty
Journal:  Subst Abus       Date:  2011-10       Impact factor: 3.716

5.  Financial factors and the implementation of medications for treating opioid use disorders.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  J Addict Med       Date:  2012-12       Impact factor: 3.702

6.  Program, counselor, and patient variability in the alliance: a multilevel study of the alliance in relation to substance use outcomes.

Authors:  Paul Crits-Christoph; Jessica L Hamilton; Sarah Ring-Kurtz; Robert Gallop; Bridget McClure; Agatha Kulaga; John Rotrosen
Journal:  J Subst Abuse Treat       Date:  2011-02-23

7.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15

8.  Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.

Authors:  Alexander Y Walley; Sara Lodi; Yijing Li; Dana Bernson; Hermik Babakhanlou-Chase; Thomas Land; Marc R Larochelle
Journal:  Addiction       Date:  2020-02-25       Impact factor: 6.526

9.  Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Authors:  Michael D Stein; Bradley J Anderson; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2015-07-14

10.  Quality of clinical supervision and counselor emotional exhaustion: the potential mediating roles of organizational and occupational commitment.

Authors:  Hannah K Knudsen; Paul M Roman; Amanda J Abraham
Journal:  J Subst Abuse Treat       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.